logo
Select company
Select metric
$ -22.17MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
24
Sector
25
Industry
27
History
5
$ 3.28Close
$ 0.9 - $ 3.3 52-Week Range
Ticker Information

Ticker

ARMP

Company Name

ARMATA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

ARMATA PHARMACEUTICALS INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ARMP - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -22.17M
3/31/2025$ -26.26M
12/31/2024$ -4.47M
9/30/2024$ -7.16M
6/30/2024$ 13.71M
3/31/2024$ 12.51M
12/31/2023$ -1.57M
9/30/2023$ -1.56M
6/30/2023$ -24.76M
3/31/2023$ -21.54M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARMATA PHARMACEUTICALS INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 7.7M.
  • Over the past 5 years, ARMATA PHARMACEUTICALS INC's average CF - Chg. Cash has been $ 113.5K.
  • The median CF - Chg. Cash for ARMATA PHARMACEUTICALS INC during this period was $ -1.36M
  • ARMATA PHARMACEUTICALS INC reached its highest CF - Chg. Cash over the past 5 years at $ 28.71M.
  • The lowest CF - Chg. Cash recorded by ARMATA PHARMACEUTICALS INC in the same timeframe $ -26.26M

ARMATA PHARMACEUTICALS INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
CBUS : CIBUS INC $ 6.44MACOG : ALPHA COGNITION INC $ 38.27MPYXS : PYXIS ONCOLOGY INC $ -14.34MORMP : ORAMED PHARMACEUTICALS INC $ -68.96MNTRB : NUTRIBAND INC $ 235.13KPSTV : PLUS THERAPEUTICS INC $ -2.68MDYAI : DYADIC INTERNATIONAL INC $ -2.16MALGS : ALIGOS THERAPEUTICS INC $ -26.38MTCRX : TSCAN THERAPEUTICS INC $ -72.77MIMDX : INSIGHT MOLECULAR DIAGNOSTICS INC $ 15.03M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

ARMP - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -26.26M

Minimum

Mar 31, 2025

$ 28.71M

Maximum

Mar 31, 2022

$ 113.5K

Average

$ -1.36M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.12M with a standard deviation of $ 45.01M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -137M
max$ 137.58M
average$ 1.12M
median$ 104K
std$ 45.01M